Additionally, Estradiol valerate was also identified as a potential lifespan-extending drug for both MDD with and without anxiety disorder, by targeting the G protein-coupled estrogen receptor 1 (GPER1) gene. This evidence concerns the gene GPER1 and anxiety disorder.